跳至主要内容
临床试验/NCT04675515
NCT04675515已完成不适用

CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients

Dartmouth-Hitchcock Medical Center1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2021年1月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
2
试验地点
1
主要终点
Change is smoking status

研究概览

简要总结

The purpose of this study is to assess the cessation success rates of an intensive tobacco treatment program in a patients undergoing cancer treatment at 30 days, 3 months and 6 months.

详细描述

This mixed-methods, observational cohort study will assess intensive tobacco treatment with carbon monoxide monitoring offered to all eligible smoking patients presenting for cancer treatment to the NCCC at our main Lebanon campus and our very rural St. Johnsbury campus. Subjects will not be randomized and study will not be blinded. Cessation rates among the intensive tobacco treatment will be compared to usual care, matched historical controls, and to patients who refuse all tobacco treatment program elements.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults age 18 and older
  • •Active Smoker at the time of initial consultation for cancer (defined as any smoking within 2 weeks of consult)

排除标准

  • •Adults unable to consent
  • •Prisoners

研究组 & 干预措施

Usual Tobacco Treatment

No Intervention

All individuals who are identified as tobacco users are offered tobacco treatment which includes proactive, as needed, contacts via in person, telehealth or telephone visits. for tobacco treatment, pharmacotherapy as indicated, and Quitline and SmokefreeTXT referrals

Intensive Tobacco Treatment

Experimental

Patients who consent to study participation will meet with a tobacco treatment specialist in-person initially, then biweekly via telephone or telehealth or face-to-face (or more frequently as needed). They will receive tobacco treatment counseling and support from certified tobacco treatment specialist, which may include pharmacotherapy as indicated. At enrollment, participants will undergo carbon monoxide testing using a carbon monoxide monitor. At baseline, participants will complete the Fagerström Test for Nicotine Dependence, and the Cancer Patient Tobacco Use Questionnaire (C-TUQ).

These tobacco related survey measures will be completed at 3 additional time points: 30 days, 3 months and 6 months.

干预措施: Intensive Tobacco Treatment (Behavioral)

结局指标

主要结局

Change is smoking status

时间窗: 30 days, 3 Months, 6 Months

Change in smoking status (from smoking to not smoking) of those in an intensive tobacco treatment program at 30 days, 3 months and 6 months

次要结局

  • Motivational Impact of real-time carbon monoxide monitoring(6 Months)
  • Engagement Level with Tobacco Treatment via Telehealth(6 Months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joseph D. Phillips, MD.

Staff Physician, Thoracic Surgery

Dartmouth-Hitchcock Medical Center

研究点 (1)

Loading locations...

相似试验